The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...
Module 2 included 4 patients with non-small cell lung cancer or pleural mesothelioma who had disease progression on, or were unable to tolerate, prior chemotherapy-containing regimens. Docetaxel is ...
The investigators used ICD-10 codes to identify patients in the database whose first hospital event met these criteria: (1) a diagnosis of liver cirrhosis; (2) inpatient pleural fluid cell counts ...